Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.53 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | GFER | P55789 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HTR1A | P08908 | 2/20 | 0.43 |
| ▸ | HTR7 | P34969 | 2/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | BPTF | Q12830 | 1/20 | 0.42 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2711488 | 0.84 | ALDH1A1 (0.73) | ALDH1A1NPSR1GAAGFERLMNA | |
| Hydrochloric Acid SCHEMBL3570335 | 0.83 | ALDH1A1 (0.71) | ALDH1A1NPSR1GAAGFERLMNA | |
| SCHEMBL13116822 | 0.79 | ALDH1A1 (0.66) | ALDH1A1NPSR1GAAGFERLMNA | |
| SCHEMBL9986673 | 0.76 | ALDH1A1 (0.45) | ALDH1A1NPSR1GAAGFERLMNA | |
| SCHEMBL233425 | 0.74 | ADRB1 (0.63) | ALDH1A1GFERLMNAMAPTHTR1A | |
| SCHEMBL894537 | 0.74 | ADRB1 (0.63) | ALDH1A1GFERLMNAMAPTHTR1A | |
| Bromide SCHEMBL10674981 | 0.73 | ADRB1 (0.61) | ALDH1A1GFERLMNAMAPTHTR1A | |
| Hydrochloric Acid SCHEMBL1005870 | 0.73 | ADRB1 (0.61) | ALDH1A1GFERLMNAMAPTHTR1A | |
| Hydrochloric Acid SCHEMBL714521 | 0.73 | ADRB1 (0.61) | ALDH1A1GFERLMNAMAPTHTR1A | |
| Piperazine SCHEMBL7486912 | 0.73 | ADRB1 (0.61) | ALDH1A1GFERLMNAMAPTHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1546470-A | 6-phenylpyridyl-2-amine derivatives | ������ҩ������˾ | 2004-11-17 | — | — | CN | disclosed |
| CN-1168719-C | 6-phenylpyridin-2-ylamine derivatives, pharmaceutical compositions and uses | ������ҩ������˾ | 2004-09-29 | — | — | CN | disclosed |
| EP-0891332-B1 | 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES | PFIZER (US) | 2004-03-17 | — | — | EP | disclosed |
| US-6465491-B2 | NITRIC OXIDE SYNTHASE INHIBITOR; NERVOUS SYSTEM DISORDERS | PFIZER INC. | 2002-10-15 | — | — | US | disclosed |
| US-20010034348-A1 | 6-phenylpyridyl-2-amine derivatives | LOWE JOHN A (US) | 2001-10-25 | — | — | US | disclosed |
| US-6235747-B1 | NITRIC OXIDE SYNTHASE INHIBITOR | PFIZER INC. | 2001-05-22 | — | — | US | disclosed |
| CN-1215391-A | 6-phenylpyridyl-2-amine derivatives | PFIZER (US) | 1999-04-28 | — | — | CN | disclosed |
| EP-0891332-A1 | 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES | PFIZER INC. (US) | 1999-01-20 | — | — | EP | disclosed |
| WO-1997036871-A1 | 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES | PFIZER INC. (US) | 1997-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034348-A1 | 6-phenylpyridyl-2-amine derivatives | NOS2, NOS3, NOS1 | ALDH1A1 1322/4885NPSR1 211/4885GAA 759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.